A prospective longitudinal study to assess the relation between patient characteristics and the duration of use in patients who start Selective Serotonin Reeuptake Inhibotor treatment.

A prospective longitudinal study to assess the relation between patient characteristics and the duration of use in patients who start Selective Serotonin Reeuptake Inhibotor treatment. - Relation between patient characteristics and duration of SSRI use

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30193

Enrollment

170

Registered

2006-12-21

Start date

2006-04-15

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male or female aged over 18; prescription of a SSRI prescribed by GP

Exclusion criteria

Exclusion criteria: Use of antidepressant one year before the start of this new treatment episode

Design outcomes

Primary

Measure	Time frame
Outcome variable: time from start of SSRI treatment to discontinuation of antidepressant use. Switching from the initial SSRI to another antidepressant will be considered as continuation of treatment. The assessment of the duration of antidepressant use will be primary based on patient reports, which will be confirmed by pharmacy data. Determinants: * Beliefs about and attitudes towards antidepressants * Patients* characteristics (age, gender, socio-economic variables) * Health characteristics (severity of symptoms of depression / anxiety, health status) * Drug characteristics (type of SSRI, dose, switching of antidepressant, previous antidepressant use, co-medication (benzodiazepines), effectiveness, side effects, adherence * Health care related variables (communication with physician / pharmacy, satisfaction with information)	—

Measure

Time frame

Outcome variable: time from start of SSRI treatment to discontinuation of antidepressant use. Switching from the initial SSRI to another antidepressant will be considered as continuation of treatment. The assessment of the duration of antidepressant use will be primary based on patient reports, which will be confirmed by pharmacy data. Determinants: * Beliefs about and attitudes towards antidepressants * Patients* characteristics (age, gender, socio-economic variables) * Health characteristics (severity of symptoms of depression / anxiety, health status) * Drug characteristics (type of SSRI, dose, switching of antidepressant, previous antidepressant use, co-medication (benzodiazepines), effectiveness, side effects, adherence * Health care related variables (communication with physician / pharmacy, satisfaction with information)

—

Countries

Netherlands

Outcome results